Watch Your Transfections ... Literally

There is always room for improvement, even for products that were good from the start. Take cationic liposome-based reagents, for example. Researchers have widely used such compounds to efficiently introduce nucleic acids into cells for over a decade. Qbiogene of Carlsbad, Calif., recently improved on this technology with the introduction of in vivo and in vitro FluoroFectin™ reagents, developed in the laboratory of Yechezkel Barenholz of the Hebrew University in Jerusalem. FluoroFectin

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

There is always room for improvement, even for products that were good from the start. Take cationic liposome-based reagents, for example. Researchers have widely used such compounds to efficiently introduce nucleic acids into cells for over a decade. Qbiogene of Carlsbad, Calif., recently improved on this technology with the introduction of in vivo and in vitro FluoroFectin™ reagents, developed in the laboratory of Yechezkel Barenholz of the Hebrew University in Jerusalem.

FluoroFectin reagents are fluorescently tagged, cationic liposome-based reagents that, unlike conventional transfection reagents, allow visualization of transfection events. They are available in a variety of formulations: dioleoyltrimethylammonium propane (DOTAP); DOTAP/dioleoylphosphatidylethanolamine (DOPE), for transfection of insect cells; and DOTAP/Cholesterol, for enhanced transfection efficiency. A specialized version of DOTAP/Cholesterol is available for in vivo research. FluoroFectin reagents offer an alternative to reporter gene assays and can be used in high-throughput fluorescence-activated cell-sorting (FACS) analysis. According to product manager Jane MacDougall, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies